Regarding the role of IL-22 in tumour immunity, IL-22-producing CD4 T cells were discovered in malignant pleural effusion, gastric cancer, pancreatic cancer, colorectal cancer, and B-chronic lymphocytic leukaemia. This evidence concerns the gene IL22 and pancreatic neoplasm.